Symposium
Metabolism-based Cancer Therapy Symposium 2024
● Online
Welcome
In the last decade cancer metabolism has emerged as a cancer hallmark. Although it has been almost a century since Otto Warburg described a difference in cellular metabolism in cancer cells, cancer-specific metabolic alterations have not been fully exploited therapeutically. Increasing numbers of studies showed both the complexity and the promise of targeting metabolism as a therapeutic strategy in cancer. It is time for scientists and clinicians working on this strategy to meet and exchange their experience.
With a translational focus, the symposium brings together oncologists and researchers interested in exploiting the metabolic bias of tumors for therapeutic interventions. It aims to shed light and bring to discussion novel translational approaches that are either currently under clinical testing or show translational potential in preclinical studies.
Regards
Dr. med. Ekaterina Balaian
Prof. Martin Bornhäuser
Prof. Dr. med. Triantafyllos Chavakis
Dr. Mohamed Elgendy
Prof. Dr. Leoni Kunz-Schughart
Location
Online via Zoom
Registration
Please register via the link. Thank you very much!
The CME credits have been applied for at the Saxon State Medical Association. We expect approx. 4 continuing medical education credits.
Program
12:00 a.m – 12:20 a.m. CET
Welcome and Opening Remarks
Ekaterina Balaian, Dresden, Germany
Mohamed Elgendy, Dresden, Germany
Session 1: Metabolism and its impact on metastasis and the tumor microenvironment
12:20 – 12:40 p.m. CET
Chronic stress increases metastasis via neutrophil-mediated changes to the microenvironment
Massimiliano Mazzone, Leuven, Belgium
12:50 – 1:10 p.m. CET
Spatial metabolomics or lipidomics
Johann Swinnen, Leuven, Belgium
1:20 - 1:40 p.m. CET: Break
Session 2: Innovative technologies in cancer metabolism and biomarker discovery
1:40 – 2:00 p.m. CET
Targeting mitochondria and glutamine pathway in myeloid malignancies
Natalia Baran, Houston, USA
2:10 – 2:30 p.m. CET
Leveraging AI/ML for Deep Dive Metabolomics in Biomarker Disscovery
Facundo Fernández, Atlanta, USA
2:40 – 3:00 p.m. CET: Break
Session 3: Immunometabolism: From inflammation control to CAR/T cell therapy
3:00 – 3:20 p.m. CET
Metabolic checkpoints controlling onset and resolution of inflammation
Gerhard Krönke, Berlin, Germany
3:30 – 3:50 p.m. CET
Reprogramming of immunometabolism of CAR/T cells
Camille Bigenwald, Villejuif Cedex, France
4:00 – 4:15 p.m. CET
Concluding remarks, outlook, sponsor acknowledgment and Closing
Ekaterina Balaian, Dresden, Germany
Mohamed Elgendy, Dresden, Germany
Scientific direction
Dr. med. Ekaterina Balaian, Medical Clinic 1, University Hospital Carl Gustav Carus Dresden, Technische Universität Dresden
Prof. Dr. Leoni Kunz-Schughart, OncoRay - National Center of Radiation Research in Oncology, University Hospital Carl Gustav Carus Dresden, Technische Universität Dresden
Prof. Martin Bornhäuser, Medical Clinic 1, University Hospital Carl Gustav Carus Dresden, Technische Universität Dresden
Dr. Mohamed Elgendy, Institute for Clinical Chemistry, University Hospital Carl Gustav Carus Dresden, Technische Universität Dresden
Prof. Dr. med. Triantafyllos Chavakis, Institute for Clinical Chemistry, University Hospital Carl Gustav Carus Dresden, Technische Universität Dresden
Speakers
114, rue Edouard-Vaillant, 94 805 Villejuif Cedex, France
ES&T L1244, 901 Atlantic Drive, 901 Atlantic Drive, Atlanta, GA 30332, USA
Charité Mitte, Charitépl. 1, 10117 Berlin, Germany
Herestraat 49, box 912, 3000 Leuven, Belgium
ON5 Herestraat 49 - box 825, 3000 Leuven, Belgium
Sponsor
Novartis Pharma GmbH (2.000,00 €)
WE THANK OUR SPONSOR FOR THEIR KIND SUPPORT!